Methods and treatment for reducing the risk of an inflammatory response
US11090331B2 · kind B2 · utility
0Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | May 15, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M1/0272
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology. Methods for reducing the risk of an inflammatory response in a sickle cell patient in need of a blood transfusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.